Three-Dimensional Tumor Molds Made from Imaging to Guide Tissue Sampling

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial uses 3D-printed molds derived from radiologic images to guide where tissue samples are taken from tumors during surgery. The goal is to improve the accuracy and consistency of histopathologic sampling across different tumor regions. The study involves participants with malignant or likely malignant tumors undergoing surgical procedures and aims to see if mold-guided sampling can enhance tumor characterization and potentially support more personalized treatment planning. The design centers on a surgical workflow modification with ex vivo tissue sampling using the printed molds. No phase designation is listed for this interventional study.

Why it matters

Who can join: the full rules

Inclusion Criteria:

To be eligible for the study, the study candidate must:

* be willing and able to give informed consent and give their written consent for the participation in the study (in case of a child (\<15-year-old), the consent is collected in an age-appropriate manner from the study candidate and their legal guardian(s))
* have a malignant or likely malignant tumor/tumors and undergo a surgical operation.

Exclusion Criteria:

To be eligible for the study, the study candidate cannot:

* lack the capacity to provide informed consent (if a legal guardian objects to the participation of their child (\<15-year-old), the child is not eligible);
* be at risk of having their standard of care treatment jeopardized by the study, in the opinion of their physician.

Where it's running

• Tampere University Hospital
  Tampere, Finland Recruiting

Study contacts

• Study coordinator: Otso Arponen, MD
• Email: otso.arponen@tuni.fi
• Phone: +359 3 311 611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• What causes vulnerability in older adults with serious diseases and how it affects care decisions

  This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.

  Recruiting Tampere University Hospital · Tampere · NCT07740239

• One Year of Intensive Lifestyle Treatment for Children with ISO-BMI Over 30 and Their Families

  This trial tests a year-long intensive lifestyle program for kids aged 10–16 with ISO-BMI of 30 or higher, and also involves their families.

  Recruiting Tampere University Hospital · Tampere, Pirkanmaa · NCT07738029

• Bergen Four-Day Treatment for OCD, in Finland

  This trial tests whether the Bergen Four-Day Treatment for OCD can be implemented in Finnish psychiatric care to help people with OCD see if the intensive program works in a real-world setting.

  Recruiting Tampere University Hospital · Tampere · NCT07644130

• Treatments for prolonged cough in children

  It tests whether an inhaled steroid helps children with dry prolonged cough and whether an antibiotic helps children with wet prolonged cough compared with placebo.

  Recruiting Phase 3 Tampere University Hospital · Tampere · NCT07582549

• 24-hour continuous antibiotic infusion for children using portable elastomeric pumps

  This will try 24-hour continuous IV antibiotic infusions with portable elastomeric pumps for children who need intravenous antibiotics to see if the approach is safe and cost-saving for home care.

  Recruiting Phase 3 Tampere University Hospital · Tampere · NCT07575009

• Comparing the Manchester procedure versus vaginal hysterectomy for uterine prolapse

  This study tests whether the Manchester procedure or vaginal hysterectomy works better for women with symptomatic uterine prolapse over a two-year follow-up.

  Recruiting at 6 sites Tampere University Hospital · Helsinki and 5 other locations · NCT07566949

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.